Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Cogent Biosciences (COGT) Shares Issued (2017 - 2026)

Cogent Biosciences' Shares Issued history spans 10 years, with the latest figure at $1.1 million for Q1 2026.

  • Quarterly Shares Issued rose 81.85% to $1.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $12.0 million through Mar 2026, up 1435.63% year-over-year, with the annual reading at $11.5 million for FY2025, 5702.01% up from the prior year.
  • Shares Issued came in at $1.1 million for Q1 2026, up from -$204.2 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $215.7 million in Q3 2025 to a low of -$204.2 million in Q4 2025.
  • The 5-year median for Shares Issued is $314000.0 (2022), against an average of $12.6 million.
  • The largest YoY upside for Shares Issued was 342203.17% in 2025 against a maximum downside of 756566.67% in 2025.
  • Cogent Biosciences' Shares Issued stood at $315000.0 in 2022, then surged by 106.98% to $652000.0 in 2023, then plummeted by 95.86% to $27000.0 in 2024, then tumbled by 756566.67% to -$204.2 million in 2025, then surged by 100.52% to $1.1 million in 2026.
  • Per Business Quant, the three most recent readings for COGT's Shares Issued are $1.1 million (Q1 2026), -$204.2 million (Q4 2025), and $215.7 million (Q3 2025).